Skip to main content

Hypercoagulable State Associated With COVID-19 Infection

Learning objectives:

  -  Identify key coagulation markers that are associated with increasedmortality in

     COVID-19 infected patients

  -  Distinguish COVID-19 hypercoagulability from other hypercoagulable states

  -  Understand key laboratory issues associated with thrombophilia testing and

     anticoagulant monitoring in patients with COVID-19 infection


Nov 12, 2020


  -  Frederick K Racke,  MD, PhD., Medical Director,

     Hematology/Oncology and Coagulation, Nichols Institute,

     Quest Diagnostics, San Juan Capistrano, CA


  -  Edward C. Wong, MD, Medical Director, Quest

     Diagnostics; Adj Assoc Professor, George Washington

     School of Medicine and Health Sciences; Clinical

     Consultant, Children’s National Hospital